0 XP   0   0   0

Indiva Ltd
Buy, Hold or Sell?

I guess you are interested in Indiva Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Indiva

Let's start. I'm going to help you getting a better view of Indiva Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Indiva Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Indiva Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Indiva Ltd. The closing price on 2022-09-30 was $0.1 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Indiva Ltd Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Indiva Ltd.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Indiva earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Indiva to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -47.9% means that $-0.48 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Indiva Ltd:

  • The MRQ is -30.8%. The company is making a huge loss. -2
  • The TTM is -47.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-30.8%TTM-47.9%+17.1%
TTM-47.9%YOY-70.0%+22.1%
TTM-47.9%5Y-508.1%+460.1%
5Y-508.1%10Y-508.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.8%0.8%-31.6%
TTM-47.9%1.0%-48.9%
YOY-70.0%1.7%-71.7%
5Y-508.1%0.6%-508.7%
10Y-508.1%1.2%-509.3%
1.1.2. Return on Assets

Shows how efficient Indiva is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Indiva to the Drug Manufacturers-Specialty & Generic industry mean.
  • -9.6% Return on Assets means that Indiva generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Indiva Ltd:

  • The MRQ is -6.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-9.6%+3.1%
TTM-9.6%YOY-9.0%-0.6%
TTM-9.6%5Y-8.1%-1.5%
5Y-8.1%10Y-8.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.5%0.2%-6.7%
TTM-9.6%0.2%-9.8%
YOY-9.0%0.1%-9.1%
5Y-8.1%-0.1%-8.0%
10Y-8.1%0.2%-8.3%
1.1.3. Return on Equity

Shows how efficient Indiva is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Indiva to the Drug Manufacturers-Specialty & Generic industry mean.
  • -37.2% Return on Equity means the company generated $-0.37 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Indiva Ltd:

  • The MRQ is -37.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -38.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.2%TTM-38.1%+1.0%
TTM-38.1%YOY-25.9%-12.2%
TTM-38.1%5Y-19.6%-18.5%
5Y-19.6%10Y-19.6%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.2%0.8%-38.0%
TTM-38.1%0.6%-38.7%
YOY-25.9%0.6%-26.5%
5Y-19.6%0.1%-19.7%
10Y-19.6%0.5%-20.1%

1.2. Operating Efficiency of Indiva Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Indiva is operating .

  • Measures how much profit Indiva makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Indiva to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -16.3% means the company generated $-0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Indiva Ltd:

  • The MRQ is -16.3%. The company is operating very inefficient. -2
  • The TTM is -17.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16.3%TTM-17.1%+0.8%
TTM-17.1%YOY-36.6%+19.5%
TTM-17.1%5Y-474.0%+456.9%
5Y-474.0%10Y-474.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.3%3.5%-19.8%
TTM-17.1%2.3%-19.4%
YOY-36.6%3.9%-40.5%
5Y-474.0%3.5%-477.5%
10Y-474.0%1.9%-475.9%
1.2.2. Operating Ratio

Measures how efficient Indiva is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 189.6% means that the operating costs are $1.90for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Indiva Ltd:

  • The MRQ is 1.896. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.931. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.896TTM1.931-0.035
TTM1.931YOY2.436-0.504
TTM1.9315Y6.101-4.169
5Y6.10110Y6.1010.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8961.483+0.413
TTM1.9311.435+0.496
YOY2.4361.382+1.054
5Y6.1011.363+4.738
10Y6.1011.160+4.941

1.3. Liquidity of Indiva Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Indiva is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 100.6% means the company has $1.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Indiva Ltd:

  • The MRQ is 1.006. The company is just able to pay all its short-term debts.
  • The TTM is 1.250. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.006TTM1.250-0.244
TTM1.250YOY1.083+0.167
TTM1.2505Y9.966-8.716
5Y9.96610Y9.9660.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0061.887-0.881
TTM1.2501.900-0.650
YOY1.0832.104-1.021
5Y9.9662.156+7.810
10Y9.9661.840+8.126
1.3.2. Quick Ratio

Measures if Indiva is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 33.1% means the company can pay off $0.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Indiva Ltd:

  • The MRQ is 0.331. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.443. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.331TTM0.443-0.111
TTM0.443YOY0.352+0.090
TTM0.4435Y0.304+0.139
5Y0.30410Y0.3040.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3310.638-0.307
TTM0.4430.784-0.341
YOY0.3520.809-0.457
5Y0.3040.838-0.534
10Y0.3040.834-0.530

1.4. Solvency of Indiva Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Indiva assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.83 means that Indiva assets are financed with 82.5% credit (debt) and the remaining percentage (100% - 82.5%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Indiva Ltd:

  • The MRQ is 0.825. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.752. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.825TTM0.752+0.073
TTM0.752YOY0.605+0.147
TTM0.7525Y0.458+0.294
5Y0.45810Y0.4580.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8250.429+0.396
TTM0.7520.412+0.340
YOY0.6050.391+0.214
5Y0.4580.390+0.068
10Y0.4580.396+0.062
1.4.2. Debt to Equity Ratio

Measures if Indiva is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 471.7% means that company has $4.72 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Indiva Ltd:

  • The MRQ is 4.717. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.223. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.717TTM3.223+1.494
TTM3.223YOY1.612+1.611
TTM3.2235Y1.297+1.926
5Y1.29710Y1.2970.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7170.695+4.022
TTM3.2230.677+2.546
YOY1.6120.624+0.988
5Y1.2970.678+0.619
10Y1.2970.689+0.608

2. Market Valuation of Indiva Ltd

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Indiva.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -1.10 means the investor is paying $-1.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Indiva Ltd:

  • The EOD is -0.906. Company is losing money. -2
  • The MRQ is -1.105. Company is losing money. -2
  • The TTM is -2.017. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.906MRQ-1.105+0.199
MRQ-1.105TTM-2.017+0.913
TTM-2.017YOY-1.979-0.038
TTM-2.0175Y-2.399+0.382
5Y-2.39910Y-2.3990.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.9060.342-1.248
MRQ-1.1050.416-1.521
TTM-2.0171.360-3.377
YOY-1.9793.493-5.472
5Y-2.3996.176-8.575
10Y-2.3996.811-9.210
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Indiva.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Indiva Ltd:

  • The MRQ is 0.079. Very good. +2
  • The TTM is 0.018. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.079TTM0.018+0.061
TTM0.018YOY-0.108+0.126
TTM0.0185Y-0.069+0.087
5Y-0.06910Y-0.0690.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0790.003+0.076
TTM0.0180.020-0.002
YOY-0.1080.032-0.140
5Y-0.0690.026-0.095
10Y-0.0690.028-0.097

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Indiva is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 2.65 means the investor is paying $2.65 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Indiva Ltd:

  • The EOD is 2.170. Good. +1
  • The MRQ is 2.648. Good. +1
  • The TTM is 3.199. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.170MRQ2.648-0.477
MRQ2.648TTM3.199-0.551
TTM3.199YOY1.990+1.209
TTM3.1995Y1.175+2.024
5Y1.17510Y1.1750.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD2.1701.442+0.728
MRQ2.6481.617+1.031
TTM3.1992.042+1.157
YOY1.9902.274-0.284
5Y1.1752.006-0.831
10Y1.1751.538-0.363

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Indiva Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0460.071-35%0.139-67%0.073-37%0.073-37%
Book Value Per Share Growth---0.018-0.023+26%-0.011-41%0.004-541%0.004-541%
Current Ratio--1.0061.250-20%1.083-7%9.966-90%9.966-90%
Debt To Asset Ratio--0.8250.752+10%0.605+36%0.458+80%0.458+80%
Debt To Equity Ratio--4.7173.223+46%1.612+193%1.297+264%1.297+264%
Dividend Per Share----0%-0%-0%-0%
Eps---0.017-0.028+61%-0.032+87%-0.027+57%-0.027+57%
Eps Growth---13.956-14.839+6%25.196-155%11.072-226%11.072-226%
Gains Per Share---0.018-0.023+26%-0.011-41%0.004-541%0.004-541%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.308-0.479+56%-0.700+127%-5.081+1550%-5.081+1550%
Operating Margin---0.163-0.171+5%-0.366+125%-4.740+2815%-4.740+2815%
Operating Ratio--1.8961.931-2%2.436-22%6.101-69%6.101-69%
Pb Ratio2.170-22%2.6483.199-17%1.990+33%1.175+125%1.175+125%
Pe Ratio-0.906+18%-1.105-2.017+83%-1.979+79%-2.399+117%-2.399+117%
Peg Ratio--0.0790.018+330%-0.108+236%-0.069+187%-0.069+187%
Price Per Share0.100-22%0.1220.233-48%0.272-55%0.326-63%0.326-63%
Quick Ratio--0.3310.443-25%0.352-6%0.304+9%0.304+9%
Return On Assets---0.065-0.096+47%-0.090+38%-0.081+25%-0.081+25%
Return On Equity---0.372-0.381+3%-0.259-30%-0.196-47%-0.196-47%
 EOD+2 -1MRQTTM+11 -7YOY+6 -125Y+7 -1110Y+7 -11

3.2. Fundamental Score

Let's check the fundamental score of Indiva Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.906
Price to Book Ratio (EOD)Between0-12.170
Net Profit Margin (MRQ)Greater than0-0.308
Operating Margin (MRQ)Greater than0-0.163
Quick Ratio (MRQ)Greater than10.331
Current Ratio (MRQ)Greater than11.006
Debt to Asset Ratio (MRQ)Less than10.825
Debt to Equity Ratio (MRQ)Less than14.717
Return on Equity (MRQ)Greater than0.15-0.372
Return on Assets (MRQ)Greater than0.05-0.065
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Indiva Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.784
Ma 20Greater thanMa 500.108
Ma 50Greater thanMa 1000.114
Ma 100Greater thanMa 2000.128
OpenGreater thanClose0.089
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets38,500
Total Liabilities31,766
Total Stockholder Equity6,734
 As reported
Total Liabilities 31,766
Total Stockholder Equity+ 6,734
Total Assets = 38,500

Assets

Total Assets38,500
Total Current Assets11,996
Long-term Assets11,996
Total Current Assets
Cash And Cash Equivalents 2,513
Net Receivables 3,954
Inventory 4,902
Other Current Assets 457
Total Current Assets  (as reported)11,996
Total Current Assets  (calculated)11,827
+/- 169
Long-term Assets
Property Plant Equipment 21,748
Intangible Assets 1,762
Other Assets 2,994
Long-term Assets  (as reported)26,504
Long-term Assets  (calculated)26,504
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities11,930
Long-term Liabilities19,836
Total Stockholder Equity6,734
Total Current Liabilities
Short Long Term Debt 2,767
Accounts payable 8,765
Other Current Liabilities 74
Total Current Liabilities  (as reported)11,930
Total Current Liabilities  (calculated)11,607
+/- 323
Long-term Liabilities
Long term Debt 18,627
Capital Lease Obligations Min Short Term Debt641
Other Liabilities 717
Long-term Liabilities Other 717
Long-term Liabilities  (as reported)19,836
Long-term Liabilities  (calculated)20,702
+/- 866
Total Stockholder Equity
Common Stock57,230
Retained Earnings -62,123
Other Stockholders Equity 5,782
Total Stockholder Equity (as reported)6,734
Total Stockholder Equity (calculated)888
+/- 5,846
Other
Capital Stock57,230
Common Stock Shares Outstanding 146,150
Net Debt 18,882
Net Invested Capital 28,129
Net Tangible Assets 4,972
Net Working Capital 66



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
7,223
27,549
39,721
38,270
37,427
35,846
32,202
30,188
31,038
38,105
41,099
40,194
41,720
39,167
46,622
44,443
43,744
42,441
40,977
38,500
38,50040,97742,44143,74444,44346,62239,16741,72040,19441,09938,10531,03830,18832,20235,84637,42738,27039,72127,5497,223
   > Total Current Assets 
1,861
22,078
34,144
29,182
26,478
22,909
11,556
6,793
6,144
10,513
13,400
12,615
14,310
12,221
19,411
17,547
16,741
15,514
14,514
11,996
11,99614,51415,51416,74117,54719,41112,22114,31012,61513,40010,5136,1446,79311,55622,90926,47829,18234,14422,0781,861
       Cash And Cash Equivalents 
1,158
21,304
33,095
27,251
24,308
19,566
8,158
3,876
453
631
1,056
409
420
314
7,096
3,384
2,596
2,480
2,382
2,513
2,5132,3822,4802,5963,3847,0963144204091,0566314533,8768,15819,56624,30827,25133,09521,3041,158
       Short-term Investments 
0
89
0
67
0
0
97
97
0
0
0
0
0
0
0
0
0
0
0
0
000000000000979700670890
       Net Receivables 
304
196
285
349
542
599
322
229
183
826
1,973
1,131
3,358
4,725
5,957
6,716
4,636
5,870
5,806
3,954
3,9545,8065,8704,6366,7165,9574,7253,3581,1311,973826183229322599542349285196304
       Other Current Assets 
0
0
0
0
88
1,444
20
15
8
38
38
37
290
494
216
696
312
383
521
457
457521383312696216494290373838815201,444880000
   > Long-term Assets 
0
0
0
0
0
0
20,646
23,395
24,893
27,592
27,699
27,580
27,409
26,947
27,211
26,896
27,003
26,927
26,463
26,504
26,50426,46326,92727,00326,89627,21126,94727,40927,58027,69927,59224,89323,39520,646000000
       Property Plant Equipment 
5,264
5,359
5,452
5,664
7,552
9,278
17,186
18,696
19,842
22,467
22,910
22,460
22,937
22,693
23,012
22,810
22,612
22,456
21,853
21,748
21,74821,85322,45622,61222,81023,01222,69322,93722,46022,91022,46719,84218,69617,1869,2787,5525,6645,4525,3595,264
       Long Term Investments 
0
0
0
0
0
0
1,852
3,134
3,247
1,767
1,591
1,445
0
0
0
0
0
0
0
0
000000001,4451,5911,7673,2473,1341,852000000
       Intangible Assets 
60
94
125
158
154
346
298
208
210
9
9
9
2,134
2,082
2,030
1,978
1,926
1,866
1,814
1,762
1,7621,8141,8661,9261,9782,0302,0822,1349992102082983461541581259460
       Long-term Assets Other 
0
0
0
0
0
0
20,646
23,395
24,893
27,592
0
0
0
0
0
0
0
0
0
0
000000000027,59224,89323,39520,646000000
> Total Liabilities 
3,086
8,729
5,650
6,055
5,736
6,451
6,297
6,357
9,698
18,813
23,527
23,076
23,865
27,948
26,148
25,478
30,840
30,111
31,542
31,766
31,76631,54230,11130,84025,47826,14827,94823,86523,07623,52718,8139,6986,3576,2976,4515,7366,0555,6508,7293,086
   > Total Current Liabilities 
3,086
353
581
798
1,507
6,451
1,720
6,357
9,698
16,541
19,407
19,449
15,127
24,032
13,342
12,333
17,463
8,589
11,821
11,930
11,93011,8218,58917,46312,33313,34224,03215,12719,44919,40716,5419,6986,3571,7206,4511,5077985813533,086
       Short-term Debt 
744
8,093
5,069
0
0
0
0
0
4,976
0
0
0
0
0
0
0
0
0
0
0
000000000004,976000005,0698,093744
       Short Long Term Debt 
744
8,093
5,069
575
0
4,398
4,577
4,770
4,976
6,233
6,780
6,001
4,024
9,697
0
0
0
701
2,681
2,767
2,7672,6817010009,6974,0246,0016,7806,2334,9764,7704,5774,39805755,0698,093744
       Accounts payable 
242
353
581
598
685
1,038
1,660
1,562
4,694
8,571
8,483
9,199
6,476
7,254
6,535
6,160
6,591
6,304
6,757
8,765
8,7656,7576,3046,5916,1606,5357,2546,4769,1998,4838,5714,6941,5621,6601,038685598581353242
       Other Current Liabilities 
2,100
0
0
199
823
1,015
21
106
66
1,408
3,739
3,734
3,627
5,102
5,346
4,171
9,870
124
61
74
74611249,8704,1715,3465,1023,6273,7343,7391,40866106211,015823199002,100
   > Long-term Liabilities 
0
0
0
0
0
0
4,577
0
0
2,272
4,120
3,627
8,738
3,916
12,806
13,145
13,377
21,521
19,721
19,836
19,83619,72121,52113,37713,14512,8063,9168,7383,6274,1202,272004,577000000
       Other Liabilities 
0
282
0
0
0
0
0
0
0
0
0
414
726
763
739
746
714
731
715
717
7177157317147467397637264140000000002820
> Total Stockholder Equity
4,137
18,820
34,071
32,215
31,691
29,395
25,905
23,831
21,340
19,292
17,572
17,118
17,854
11,220
20,474
18,966
12,905
12,331
9,435
6,734
6,7349,43512,33112,90518,96620,47411,22017,85417,11817,57219,29221,34023,83125,90529,39531,69132,21534,07118,8204,137
   Common Stock
7,252
20,484
35,767
35,767
37,309
37,283
37,283
37,283
37,283
37,487
37,487
39,501
42,238
42,416
54,697
54,430
54,689
57,230
57,230
57,230
57,23057,23057,23054,68954,43054,69742,41642,23839,50137,48737,48737,28337,28337,28337,28337,30935,76735,76720,4847,252
   Retained Earnings -62,123-59,272-56,246-52,112-45,682-44,266-41,237-34,353-30,781-28,252-25,814-22,974-20,347-18,045-14,416-11,863-9,969-7,906-5,890-3,240
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
108
4,226
6,210
6,416
6,245
6,529
6,667
6,896
7,031
7,220
7,939
8,000
9,571
5,318
5,320
5,298
5,312
5,610
5,700
5,782
5,7825,7005,6105,3125,2985,3205,3189,5718,0007,9397,2207,0316,8966,6676,5296,2456,4166,2104,226108



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue32,470
Cost of Revenue-25,403
Gross Profit7,0677,067
 
Operating Income (+$)
Gross Profit7,067
Operating Expense-38,913
Operating Income-6,442-31,845
 
Operating Expense (+$)
Research Development417
Selling General Administrative11,499
Selling And Marketing Expenses-
Operating Expense38,91311,916
 
Net Interest Income (+$)
Interest Income218
Interest Expense-2,933
Net Interest Income-2,715-2,715
 
Pretax Income (+$)
Operating Income-6,442
Net Interest Income-2,715
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-15,276-324
EBIT - interestExpense = -8,272
-15,276
-12,076
Interest Expense2,933
Earnings Before Interest and Taxes (ebit)-5,340-12,343
Earnings Before Interest and Taxes (ebitda)-11,858
 
After tax Income (+$)
Income Before Tax-15,276
Tax Provision--267
Net Income From Continuing Ops-15,009-15,009
Net Income-15,009
Net Income Applicable To Common Shares-15,009
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-6,1192,715
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SKUE.OL
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SKUE.OL.

SKUE.OL Daily Candlestick Chart
AERS.LSE
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AERS.LSE.

AERS.LSE Daily Candlestick Chart
VIA.CC
6 hours ago

I found you a Death Cross on the daily chart of VIA.CC.

VIA.CC Daily Candlestick Chart
VELO.CC
6 hours ago

I found you a RSI Bearish Hidden Divergence on the daily chart of VELO.CC.

VELO.CC Daily Candlestick Chart
vBUSD.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of vBUSD.CC.

vBUSD.CC Daily Candlestick Chart
UNW.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of UNW.CC.

UNW.CC Daily Candlestick Chart
TWTR.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TWTR.CC.

TWTR.CC Daily Candlestick Chart
TMN.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TMN.CC.

TMN.CC Daily Candlestick Chart
TEL.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
WFAFY.PINK
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WFAFY.PINK.

WFAFY.PINK Daily Candlestick Chart
BOCT.BATS
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BOCT.BATS.

BOCT.BATS Daily Candlestick Chart
BATT.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BATT.NYSE ARC.

BATT.NYSE ARC Daily Candlestick Chart
ASXFY.PINK
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASXFY.PINK.

ASXFY.PINK Daily Candlestick Chart
ARKQ.BATS
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ARKQ.BATS.

ARKQ.BATS Daily Candlestick Chart
AGZ.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AGZ.NYSE ARC.

AGZ.NYSE ARC Daily Candlestick Chart
ADDDF.OTCQX
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ADDDF.OTCQX.

ADDDF.OTCQX Daily Candlestick Chart
ACWI.NASDAQ
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ACWI.NASDAQ.

ACWI.NASDAQ Daily Candlestick Chart
JQUA.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of JQUA.NYSE ARC.

JQUA.NYSE ARC Daily Candlestick Chart
ZIG.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ZIG.NYSE ARC.

ZIG.NYSE ARC Daily Candlestick Chart
YINN.NYSE ARC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of YINN.NYSE ARC.

YINN.NYSE ARC Daily Candlestick Chart
XSVM.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XSVM.NYSE ARC.

XSVM.NYSE ARC Daily Candlestick Chart
XOUT.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XOUT.NYSE ARC.

XOUT.NYSE ARC Daily Candlestick Chart
XNTK.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XNTK.NYSE ARC.

XNTK.NYSE ARC Daily Candlestick Chart